Innotech, Inc.
Ticker: IIII 5568 Airport Road
Exchange: NASDAQ-National Market Roanoke, Virginia 24012
Industry: Manufacturing (540) 362-2020

Type of Shares:Common Shares Filing Date:12/26/95
U.S. Shares:3,000,000 Offer Date:3/14/96
Non-U.S. Shares:0 Filing Range:$9.00 - $11.00
Primary Shares:3,000,000 Offer Price:$10.00
Secondary Shares:0 Gross Spread:$0.70
Offering Amount: $30,000,000 Selling:$0.40
Expenses:$900,000 Reallowance:$0.10
Shares Out After:9,526,331

ManagerTierPhone
Lehman Brothers IncorporatedLead Manager (212) 640-6129
Hambrecht & Quist IncorporatedCo-manager (415) 576-3423
Schroder Wertheim & Company, IncorporatedCo-manager (212) 492-6900

Auditor: KPMG Peat Marwick
Audited
Income
Latest
Unaudited
Income
Prior
Unaudited
Income
Balance
Sheet
12/31/95 12/31/95
Revenue:$6.44Assets:$13.53
Net Income:-$9.98Liabilities:$7.54
EPS:-$1.70Equity:$5.98

Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year,
unaudited figures are partial year

Business Description
The company is a leader in the development, manufacture and sale of lens casting fabrication systems that enable optometrists, opticians, and other optical retailers to custom fabricate high quality multifocal and single vision plastic eyeglass lenses. The company's system (the "Excalibur System"), which is based upon its patented Surface Casting technology, is capable of fabricating millions of different lenses of various styles, materials and prescriptions that the company believes constitute a substantial majority of the standard hard plastic multifocal and single vision prescriptions generally dispensed. As of February 29, 1996 the company sold over 570 Excalibur Systems worldwide since the Excalibur System was introduced in May 1993. Excalibur Systems are used by several large optical retailers such as National Vision Associates Ltd., which operates in Wal-Mart Stores, Inc., and Vision Express UK Ltd., as well as numerous independent optometrists, opticians and ophthalmologists.

Use of Proceeds
Proceeds from the proposed offering will be used to fund increases in inventory levels, purchases of capital equipment and tooling, development of new products and expansion of sales and marketing efforts and for working capital and other general corporate purposes.

Last updated: 10/28/96

©1996 IPO Data Systems, Inc. - All rights reserved.